Fast, certified assessments
Fundus photos and OCTs can be analyzed instantly — helping clinicians detect early signs of diseases such as diabetic retinopathy, AMD, glaucoma, and other retinal conditions.
Certified AI screening for signs of diseases such as diabetic retinopathy, AMD, and glaucoma — surfaced directly inside the Medibrix patient record. No separate tool, no context-switching. The clinician always makes the call.
One brick at a time
Medibrix is a modular, web-based platform built from interoperable "bricks" — booking, pre-visit questionnaires, assisted and remote refraction, follow-up, and clinical decision support. RetinaLyze's instant retinal analysis switches on as one of them, so screening lives where the rest of the workflow already happens.
Why it matters
Fundus photos and OCTs can be analyzed instantly — helping clinicians detect early signs of diseases such as diabetic retinopathy, AMD, glaucoma, and other retinal conditions.
With an AI safety net in place, optometrists can confidently broaden their menu of clinical offerings — adding more value for customers and patients.
AI becomes a second set of eyes that helps new clinicians build skills, spot subtle findings, and grow faster in their clinical journey.
Where it fits
Eye care workflows should be as seamless as the care professionals provide every day. Together with Medibrix, we're helping clinics, optical chains, and healthcare organizations create smarter, more connected patient journeys.
Book a Medibrix demo to see RetinaLyze screening inside the workflow — or learn more about the AI from RetinaLyze directly.